title: The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1.
abstract: The nuclear and oncogenic BCL-3 protein activates or represses gene transcription when bound to NF-kappaB proteins p50 and p52, yet the molecules that specifically interact with BCL-3 and drive BCL-3-mediated effects on gene expression remain largely uncharacterized. Moreover, GSK3-mediated phosphorylation of BCL-3 triggers its degradation through the proteasome, but the proteins involved in this degradative pathway are poorly characterized. Biochemical purification of interacting partners of BCL-3 led to the identification of CtBP as a molecule required for the ability of BCL-3 to repress gene transcription. CtBP is also required for the oncogenic potential of BCL-3 and for its ability to inhibit UV-mediated cell apoptosis in keratinocytes. We also defined the E3 ligase TBLR1 as a protein involved in BCL-3 degradation through a GSK3-independent pathway. Thus, our data demonstrate that the LSD1/CtBP complex is required for the repressing abilities of an oncogenic I kappaB protein, and they establish a functional link between the E3 ligase TBLR1 and NF-kappaB.
authors.affiliation: Interdisciplinary Cluster for Applied Genoproteomics (GIGA-Research), University of Liege, CHU, Sart-Tilman, Liege, Belgium.
authors.forename: Aurore
authors.initials: A
authors.lastname: Keutgens
authors.forename: Kateryna
authors.initials: K
authors.lastname: Shostak
authors.forename: Pierre
authors.initials: P
authors.lastname: Close
authors.forename: Xin
authors.initials: X
authors.lastname: Zhang
authors.forename: Benoît
authors.initials: B
authors.lastname: Hennuy
authors.forename: Marie
authors.initials: M
authors.lastname: Aussems
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Chapelle
authors.forename: Patrick
authors.initials: P
authors.lastname: Viatour
authors.forename: André
authors.initials: A
authors.lastname: Gothot
authors.forename: Marianne
authors.initials: M
authors.lastname: Fillet
authors.forename: Alain
authors.initials: A
authors.lastname: Chariot
mesh_terms: D000429:Alcohol Oxidoreductases / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D000081242:B-Cell Lymphoma 3 Protein; D002460:Cell Line; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism; D006367:HeLa Cells; D056466:Histone Demethylases / Q000378:metabolism; D006801:Humans; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism; D041681:NIH 3T3 Cells; D010089:Oxidoreductases, N-Demethylating / Q000378:metabolism; D054730:Protein Interaction Domains and Motifs; D055550:Protein Stability; D011518:Proto-Oncogene Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D011994:Recombinant Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D012097:Repressor Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D014157:Transcription Factors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*; D054875:Ubiquitination
chemical_list: D000081242:B-Cell Lymphoma 3 Protein; C000631344:BCL3 protein, human; C000631345:Bcl3 protein, mouse; D004268:DNA-Binding Proteins; D016328:NF-kappa B; D011518:Proto-Oncogene Proteins; D011994:Recombinant Proteins; D012097:Repressor Proteins; D014157:Transcription Factors; D000429:Alcohol Oxidoreductases; C096794:C-terminal binding protein; D056466:Histone Demethylases; C504076:KDM1a protein, mouse; C495195:KDM1A protein, human; D010089:Oxidoreductases, N-Demethylating; D044767:Ubiquitin-Protein Ligases; D038362:Glycogen Synthase Kinase 3